日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia

NGS定义的初始化疗后可测量残留病灶(MRD)作为急性髓系白血病的预后生物标志物

Li, Yonghong; Solis-Ruiz, Jose; Yang, Fei; Long, Nicola; Tong, Carmen H; Lacbawan, Felicitas L; Racke, Frederick K; Press, Richard D

Erratum for Elagib et al., Jun Blockade of Erythropoiesis: Role for Repression of GATA-1 by HERP2

勘误:Elagib 等人,Jun,《红细胞生成阻滞:HERP2 对 GATA-1 的抑制作用》

Elagib, Kamaleldin E; Xiao, Mang; Hussaini, Isa M; Delehanty, Lorrie L; Palmer, Lisa A; Racke, Frederick K; Birrer, Michael J; Ganapathy-Kanniappan, Shanmugasundaram; McDevitt, Michael A; Goldfarb, Adam N

Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results

在一例染色体和FISH结果正常的MDS病例中,发现5q亚显微缺失,涉及抑癌基因(CTNNA1、HSPA9),以及与TET2和EZH2突变相关的拷贝数中性杂合性缺失。

Hemmat, Morteza; Chen, Weina; Anguiano, Arturo; Naggar, Mohammed El; Racke, Frederick K; Jones, Dan; Wang, Yongbao; Strom, Charles M; Chang, Karl; Boyar, Fatih Z

Unique in vitro and in vivo thrombopoietic activities of ingenol 3,20 dibenzoate, a Ca(++)-independent protein kinase C isoform agonist.

英格醇 3,20 二苯甲酸酯是一种 Ca(++) 非依赖性蛋白激酶 C 同工酶激动剂,具有独特的体外和体内促血小板生成活性

Racke Frederick K, Baird Maureen, Barth Rolf F, Huo Tianyao, Yang Weilian, Gupta Nilendu, Weldon Michael, Rutledge Heather

Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2

Jun 阻断红细胞生成:HERP2 对 GATA-1 的抑制作用

Elagib, Kamaleldin E; Xiao, Mang; Hussaini, Isa M; Delehanty, Lorrie L; Palmer, Lisa A; Racke, Frederick K; Birrer, Michael J; Ganapathy-Kanniappan, Shanmugasundaram; McDevitt, Michael A; Goldfarb, Adam N